|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 25 MASSACHUSETTS AVENUE, NW |
Address2 | SUITE 600 |
| City | WASHINGTON |
State | DC |
Zip Code | 20001-7400 |
Country | USA |
3. Principal place of business (if different than line 2)
| City | Chicago |
State | IL |
Zip Code | 60611-5885 |
Country | USA |
|
5. Senate ID# 2877-12
|
||||||||
|
6. House ID# 304640000
|
||||||||
| TYPE OF REPORT | 8. Year | 2020 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: George E. Cox III, JD |
Date | 1/26/2021 9:49:44 AM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
H.R. 133, Consolidated Appropriations Act, 2021, provisions related to surprise medical bills, fee-for-service, telehealth, provider relief fund, sequester relief, medical journal open access reform, E/M services, and budget neutrality
H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020, all provisions
H.R. 8406, The Heroes Act, all provisions
H.R. 925, The Heroes Act, all provisions
H.R. 6800, The Heroes Act, all provisions
H.R. 6201, Families First Coronavirus Response Act, all provisions
H.R. 6379, Take Responsibility for Workers and Families Act, all provisions
H.R. 748, Coronavirus Aid, Relief, and Economic Security Act, all provisions
H.R. 266, Paycheck Protection Program and Health Care Enhancement Act, all provisions
H.R. 5184, The Health, Economic Assistance, Liability Protection, and Schools (HEALS) Act, all provisions
S. 1624, The Health, Economic Assistance, Liability Protection, and Schools (HEALS) Act, all provisions
H.R. 7617, Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021, provisions related to medical journal open access reform
FY 2021 House Commerce, Justice, Science and Related Agencies Appropriations Bill, inclusion of provisions related to medical journal open access reform, Part B
H.R. 8319, Continuing Appropriations Act, 2021, provisions related to Medicare Accelerated and Advance Payment Program changes, COVID-19 response, Medicare sequester relief
H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act, provisions related to Medicare Accelerated and Advance Payment Program changes, surprise billing, and COVID-19 response
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Lindsey |
Brill |
|
|
|
Katherine |
Dapper |
|
Staff Assistant, Sen. Patty Murray (D-WA) |
|
Dana |
Lichtenberg |
|
|
|
Christopher |
Sherin |
|
|
|
Chase |
Thomas |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Sandy |
Marks |
|
|
|
George |
Cox |
III |
|
|
Jennifer |
Brown |
|
|
|
Debra |
Cohn |
|
|
|
Alexis |
Pierce |
|
|
|
Danielle |
Turnipseed |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
H.R. 1763, Resident Physician Shortage Reduction Act of 2019, all provisions
H.R. 5654, Expanding Medical Education Act of 2020, all provisions
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Christopher |
Sherin |
|
|
|
Chase |
Thomas |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 3502, Protecting People from Surprise Medical Bills Act, all provisions
H.R. 5826, Consumer Protections Against Surprise Medical Bills Act of 2020, all provisions
H.R. 3630, No Surprises Act, all provisions
S. 1895, Lower Health Care Costs Act, provisions relating to surprise billing
S. 1531, Stopping The Outrageous Practice of (STOP) Surprise Medical Bills Act of 2019, all provisions
S. 4421, Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act, all provisions
H.R. 6644, To require group health plans and health insurance issuers offering group or individual health insurance coverage to provide coverage for services furnished via telehealth if such services would be covered if furnished in-person during the COVID-19 emergency, all provisions
S. 3741, Health Care at Home Act of 2020, all provisions
S. 4666, National Coronavirus Commission Act of 2020, all provisions
S. 4507, Getting Early Treatment and Comprehensive Assessments Reduces Emergencies (GET CARE) Act of 2020, all provisions
H.R. 8441, Frontline Heroes Act, all provisions
S. 4317, SAFE TO WORK Act, all provisions
H.R. 925, The Heroes Act, all provisions
S. 3749, Public Health Emergency Privacy Act, all provisions
S. 3861, Exposure Notification Privacy Act, all provisions
H.R. 6585, Equitable Data Collection and Disclosure on COVID-19 Act, all provisions
H.R. 7510, Assimilating Health and Equity Assessments into Decision-making (AHEAD Act) of 2020, all provisions
S. 4919, Assimilating Health and Equity Assessments into Decision-making (AHEAD Act) of 2020, all provisions
H.R. 6808, Health Force and Resilience Force Act of 2020, all provisions
S. 3606, Health Force and Resilience Force Act of 2020, all provisions
H.R. 7255, Coronavirus Health Care Worker Wellness Act of 2020, all provisions
H.R. 8094, Dr. Lorna Breen Health Care Provider Protection Act, all provisions
S. 4349, Dr. Lorna Breen Health Care Provider Protection Act, all provisions
H.R. 3884, Marijuana Opportunity Reinvestment and Expungement (MORE) Act of 2020, all provisions
S. 2032, Cannabidiol and Marihuana Research Expansion Act, all provisions
H.R. 1503, Orange Book Transparency Act of 2019, provisions related to PBM and prescription drug price transparency
H.R. 1520, Purple Book Continuity Act of 2019, provisions related to PBM and prescription drug price transparency
H.R. 987, Strengthening Health Care and Lowering Prescription Drug Costs Act, provisions related to PBM and prescription drug price transparency
H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act, provisions related to PBM and prescription drug price transparency
H.R. 4995, Maternal Health Quality Improvement Act of 2020, all provisions
H.R. 7120, George Floyd Justice in Policing Act of 2020, provisions relating to police reform
Affordable Care Act stabilization
Expansion of Paycheck Protection Program for 501(c)6s
Public Health and Social Services Emergency Fund
Marginalized and minoritized communities/COVID-19 disproportionate impact
COVID-19 long haulers
COVID-19 testing/vaccines/health care prior authorization
COVID-19/treatment and prescribing flexibilities
COVID-19/Expanded PPE/clearinghouses
E/M services
Surprise medical billing executive orders
Surprise Medical Billing, generally
Clinical and administrative data intersection
State Medical Boards/Interstate Medical Licensure Compact
Pharmacists and COVID-19 testing
Mental health parity
Digital therapeutics
Physician practice financial impact
21st Century Cures Act/health data and privacy
42 CFR Part 2, HIPAA
Patent reform
CPT - digital
Most favored nation drug pricing
Drug pricing
Health Information Technology/information blocking
Dietary guidelines/alcohol consumption
Data privacy
Cyber security best practices
Race and sex stereotyping executive order
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Drug Enforcement Administration (DEA), Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Agriculture - Dept of (USDA), White House Office, Food & Drug Administration (FDA), Centers For Disease Control & Prevention (CDC), Federal Emergency Management Agency (FEMA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Lindsey |
Brill |
|
|
|
Katherine |
Dapper |
|
Staff Assistant, Sen. Patty Murray (D-WA) |
|
Dana |
Lichtenberg |
|
|
|
Christopher |
Sherin |
|
|
|
Chase |
Thomas |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Shannon |
Curtis |
|
|
|
Laura |
Hoffman |
|
|
|
Sandy |
Marks |
|
|
|
Matthew |
Reid |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
|
Kyle |
Thomson |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
S. 948, Conrad State 30 and Physician Access Reauthorization Act, all provisions
H.R. 2895, Conrad State 30 and Physician Access Reauthorization Act, all provisions
H.R. 6788, Healthcare Workforce Resilience Act, all provisions
S. 3599, Healthcare Workforce Resilience Act, all provisions
Executive Orders related to immigration/international medical graduates
J-1 Visa/duration of status
USCIS collection and use of biometrics
H-1B Visas
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Homeland Security - Dept of (DHS), U.S. Citizenship & Immigration Services (USCIS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Lindsey |
Brill |
|
|
|
Christopher |
Sherin |
|
|
|
Chase |
Thomas |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Jason |
Scull |
|
|
|
George |
Cox |
III |
|
|
Jennifer |
Brown |
|
|
|
Alexis |
Pierce |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
Insurance market concentration
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Lindsey |
Brill |
|
|
|
Christopher |
Sherin |
|
|
|
Andrew |
Wankum |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 8840, Medicare Sequester COVID Moratorium Act, all provisions
H.R. 8702, Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020, all provisions
S. 5007, Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020, all provisions
H.R. 7154, Outpatient Therapy Modernization and Stabilization Act, all provisions
H.R. 3107, Improving Seniors Timely Access to Care Act of 2019, all provisions
S. 5044, Improving Seniors Timely Access to Care Act of 2020y, all provisions
H.R. 8727, Telehealth Modernization Act, all provisions
S. 4375, Telehealth Modernization Act, all provisions
H.R. 7663, Protecting Access to Post-COVID-19 Telehealth Act of 2020, all provisions
H.R. 7391, Protect Telehealth Access Act of 2020, all provisions
H.R. 1301, Mental Health Telemedicine Expansion Act, all provisions
H.R. 3417, Beneficiary Education Tools, Telehealth, and Extenders Reauthorization (BETTER) Act of 2019, all provisions
H.R. 5201, Telemental Health Expansion Act of 2020, provisions relating to 1834(m) of the Social Security Act; geographic and originating sites
H.R. 7233, Knowing the Efficiency and Efficacy of Permanent (KEEP) Telehealth Options Act of 2020, all provisions
H.R. 5172, Non-Opioids Prevent Addiction In the Nation (NOPAIN) Act, All provisions
S. 3067, Non-Opioids Prevent Addiction In the Nation (NOPAIN) Act, All provisions
H.R. 3414, Opioid Workforce Act of 2019, all provisions
H.R. 7791, Value in Health Care Act of 2020, provisions relating to qualifying APM physician thresholds
H.R. 6837, Medicare Accelerated and Advance Payments Improvement Act of 2020, all provisions
S. 3750, Medicare Accelerated and Advance Payments Improvement Act, all provisions
H.R. 8505, To amend title XVIII of the Social Security Act to provide for a one-year waiver of budget neutrality adjustments under the Medicare physician fee schedule, and for other purposes, all provisions
H.R. 884, Medicare Mental Health Access Act, all provisions
H.R. 945, Mental Health Access Improvement Act of 2019, all provisions
H.R. 6744, Medically Tailored Home-Delivered Meals Demonstration Pilot Act of 2020, all provisions
H.R. 4004, Social Determinants Accelerator Act of 2019, all provisions
H.R. 4932, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019, all provisions
S. 2741, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019, all provisions
H.R. 5534, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020, all provisions
S. 3353, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020, all provisions
H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act, provisions related to PBM and prescription drug price transparency
H.R. 19, Lower Costs, More Cures Act of 2019, provisions related to PBM and prescription drug price transparency
H.R. 4996, Helping Medicaid Offer Maternity Services (MOMS) Act of 2020, all provisions
H.R. 6090, Physician Shortage GME Cap Flex Act of 2020, all provisions
H.R. 6142, Black Maternal Health Momnibus Act of 2020, all provisions
Medicare program: P.L. 114-10 Medicare Access and CHIP Reauthorization Act (MACRA) implementation/Accountable Care Organizations/APM thresholds
Medicare program: Patient Protection and Affordable Care Act (PPACA)/Prior authorization provider and patient burdens/patient electronic access to health information
Medicare program: P.L. 113-93 Protecting Access to Medicare Act (PAMA)/Imaging appropriate use criteria/Radiation Oncology APM
Medicare program: FY 2021 Inpatient Rehab Facility Prospective Payment System (IRF PPS)/scope of practice issues
Medicare program: CY 2021 physician fee schedule/E&M services/Budget neutrality/Part B/Sequester
Medicare program: Alternative payment models (APMs)
Medicare program: Merit-based Incentive Payment System (MIPS)/cost/quality/interoperability/hardship exemption
Medicare program: Regulatory relief/Advanced APMs, prior authorization, and utilization management
Medicare program: Shared Savings Program
Medicare program: Quality Payment Program/prior authorization/electronic funds transfer
Medicare program: Surprise medical billing
Medicare program: Medicare-For-All
Medicare program: Electronic Health Records (EHR) Certification
Medicare program: 21st Century Cures Act
Medicare program: Quality payment program/physician burdens
Medicare program: National Coverage determination/validated home blood pressure monitors
Medicare program: Health IT/physician burden
Medicare program: Drug pricing
Medicare program: Most favored nation drug pricing
Medicare program: Provider compliance/regulatory relief
Medicare program: Provider Enrollment, Chain and Ownership (PECOS) enrollment/revalidation
Medicare and Medicaid programs: 21st Century Cures Act/health data and privacy
Medicaid program: CMS proposed regulation Medicaid Program
Medicaid program: FMAP increases
Medicaid program: Interoperability
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Drug Enforcement Administration (DEA), Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Lindsey |
Brill |
|
|
|
Katherine |
Dapper |
|
Staff Assistant, Sen. Patty Murray (D-WA) |
|
Dana |
Lichtenberg |
|
|
|
Christopher |
Sherin |
|
|
|
Chase |
Thomas |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Shannon |
Curtis |
|
|
|
Laura |
Hoffman |
|
|
|
Sandy |
Marks |
|
|
|
Jennifer |
McLaughlin |
|
|
|
Matthew |
Reid |
|
|
|
Koryn |
Rubin |
|
|
|
Jason |
Scull |
|
|
|
George |
Cox |
III |
|
|
Jennifer |
Brown |
|
|
|
Debra |
Cohn |
|
|
|
Alexis |
Pierce |
|
|
|
Kyle |
Thomson |
|
|
|
Danielle |
Turnipseed |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
H.R. 7819, Eliminating the Provider Relief Fund Tax Penalties Act of 2020, all provisions
S. 4525, Eliminating the Provider Relief Fund Tax Penalties Act of 2020, all provisions
Public Health and Social Services Emergency Fund/taxation issues
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Christopher |
Sherin |
|
|
|
George |
Cox |
III |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOB
16. Specific lobbying issues
H.R. 2339, Protecting American Lungs and Reversing the Youth Tobacco Epidemic Act of 2020, provisions related to vaping and tobacco products
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Chase |
Thomas |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOR
16. Specific lobbying issues
H.R. 7059, Coronavirus Provider Protection Act, all provisions
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Christopher |
Sherin |
|
|
|
Chase |
Thomas |
|
|
|
George |
Cox |
III |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
H.R. 8247, Veterans Comprehensive Prevention, Access to Care, and Treatment (COMPACT) Act of 2020, all provisions
S. 785, Commander John Scott Hannon Veterans Mental Health Care Improvement Act of 2019, all provisions
Scope of practice
Veterans Choice/Community Care Program
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Christopher |
Sherin |
|
|
|
Chase |
Thomas |
|
|
|
Margaret |
Garikes |
|
|
|
Jason |
Scull |
|
|
|
George |
Cox |
III |
|
|
Alexis |
Pierce |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |